Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2019. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3754255012 | 3',5'-cyclic-nucleotide phosphodiesterase inhibitor | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3754257016 | Substance with 3',5'-cyclic-nucleotide phosphodiesterase inhibitor mechanism of action (substance) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Substance with 3',5'-cyclic-nucleotide phosphodiesterase inhibitor mechanism of action (substance) | Has disposition | 3',5'-cyclic-nucleotide phosphodiesterase inhibitor | true | Inferred relationship | Existential restriction modifier | ||
| Substance with 3',5'-cyclic-nucleotide phosphodiesterase inhibitor mechanism of action (substance) | Is a | Substance categorized by disposition | false | Inferred relationship | Existential restriction modifier | ||
| Substance with 3',5'-cyclic-nucleotide phosphodiesterase inhibitor mechanism of action (substance) | Is a | Substance with hydrolase mechanism of action | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Levosimendan | Is a | False | Substance with 3',5'-cyclic-nucleotide phosphodiesterase inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Product containing 3',5'-cyclic-nucleotide phosphodiesterase inhibitor (product) | Has active ingredient | True | Substance with 3',5'-cyclic-nucleotide phosphodiesterase inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | 1 |
This concept is not in any reference sets
FHIR